Shay Shemesh - 23 Sep 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chief Dev. & Ops. Officer
Signature
/s/ Shay Shemesh
Issuer symbol
NVCT
Transactions as of
23 Sep 2022
Net transactions value
+$1,731
Form type
4
Filing time
27 Sep 2022, 08:45:28 UTC
Previous filing
06 Sep 2022
Next filing
18 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $1,731 +220 +0.02% $7.87 1,245,065 23 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 48,399 shares of restricted stock and 60,000 restricted stock units.